➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Colorcon
AstraZeneca
Boehringer Ingelheim
Harvard Business School

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

Perrigo Co Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PERRIGO CO, and what generic and branded alternatives to PERRIGO CO drugs are available?

PERRIGO CO has sixteen approved drugs.



Drugs and US Patents for Perrigo Co

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Co CICLOPIROX ciclopirox SHAMPOO;TOPICAL 078594-001 Feb 16, 2010 AT RX No No   Start Trial   Start Trial
Perrigo Co STIE-CORT hydrocortisone LOTION;TOPICAL 089074-001 Nov 26, 1985 AT RX No Yes   Start Trial   Start Trial
Perrigo Co Tennessee BACITRACIN bacitracin OINTMENT;OPHTHALMIC 061212-001 Approved Prior to Jan 1, 1982 RX No Yes   Start Trial   Start Trial
Perrigo Co Tennessee SULFACETAMIDE SODIUM sulfacetamide sodium OINTMENT;OPHTHALMIC 080029-001 Approved Prior to Jan 1, 1982 RX No Yes   Start Trial   Start Trial
Perrigo Co Tennessee ERYTHROMYCIN erythromycin OINTMENT;OPHTHALMIC 062447-001 Sep 26, 1983 AT RX No Yes   Start Trial   Start Trial
Perrigo Co CLOBETASOL PROPIONATE clobetasol propionate GEL;TOPICAL 075027-001 Oct 31, 1997 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
McKinsey
McKesson
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.